DMAC
Price
$5.71
Change
+$0.04 (+0.71%)
Updated
Jan 17 closing price
Capitalization
244.16M
66 days until earnings call
PCVX
Price
$85.30
Change
-$2.53 (-2.88%)
Updated
Jan 17 closing price
Capitalization
10.63B
44 days until earnings call
Ad is loading...

DMAC vs PCVX

Header iconDMAC vs PCVX Comparison
Open Charts DMAC vs PCVXBanner chart's image
DiaMedica Therapeutics
Price$5.71
Change+$0.04 (+0.71%)
Volume$249.08K
Capitalization244.16M
Vaxcyte
Price$85.30
Change-$2.53 (-2.88%)
Volume$1.61M
Capitalization10.63B
DMAC vs PCVX Comparison Chart
Loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DMAC vs. PCVX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a Hold and PCVX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (DMAC: $5.71 vs. PCVX: $85.30)
Brand notoriety: DMAC and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 202% vs. PCVX: 117%
Market capitalization -- DMAC: $244.16M vs. PCVX: $10.63B
DMAC [@Biotechnology] is valued at $244.16M. PCVX’s [@Biotechnology] market capitalization is $10.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, DMAC is a better buy in the long-term than PCVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 5 bullish TA indicator(s).

  • DMAC’s TA Score: 4 bullish, 4 bearish.
  • PCVX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than DMAC.

Price Growth

DMAC (@Biotechnology) experienced а +8.35% price change this week, while PCVX (@Biotechnology) price change was +5.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

DMAC is expected to report earnings on May 19, 2025.

PCVX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($10.6B) has a higher market cap than DMAC($244M). DMAC YTD gains are higher at: 5.157 vs. PCVX (4.202). DMAC has higher annual earnings (EBITDA): -24.07M vs. PCVX (-528.22M). PCVX has more cash in the bank: 2.18B vs. DMAC (50.2M). DMAC has less debt than PCVX: DMAC (365K) vs PCVX (28M). DMAC (0) and PCVX (0) have equivalent revenues.
DMACPCVXDMAC / PCVX
Capitalization244M10.6B2%
EBITDA-24.07M-528.22M5%
Gain YTD5.1574.202123%
P/E RatioN/AN/A-
Revenue00-
Total Cash50.2M2.18B2%
Total Debt365K28M1%
FUNDAMENTALS RATINGS
DMAC: Fundamental Ratings
DMAC
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DMACPCVX
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
82%
Momentum
ODDS (%)
Bullish Trend 11 days ago
88%
Bearish Trend 11 days ago
82%
MACD
ODDS (%)
Bearish Trend 11 days ago
77%
Bullish Trend 11 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
85%
Bearish Trend 11 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
83%
Bearish Trend 11 days ago
81%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 26 days ago
81%
Bearish Trend 23 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
89%
Bullish Trend 11 days ago
84%
Aroon
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
82%
View a ticker or compare two or three
Ad is loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NGISX16.630.17
+1.03%
Nationwide BNY Mellon Dyn US Core I.S
CSXCX47.270.45
+0.96%
Calvert US Large Cap Core Rspnb Idx C
UGMVX10.90N/A
N/A
Victory Global Managed Volatility
RIOIX8.57N/A
N/A
RBC International Opportunities I
KCRIX8.13-0.02
-0.25%
Knights of Columbus Real Estt I

DMAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with AADI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then AADI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
+0.71%
AADI - DMAC
40%
Loosely correlated
-4.79%
AVXL - DMAC
26%
Poorly correlated
-9.26%
PCVX - DMAC
26%
Poorly correlated
-2.88%
STTK - DMAC
24%
Poorly correlated
+1.83%
VTGN - DMAC
23%
Poorly correlated
N/A
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-2.88%
ORKA - PCVX
59%
Loosely correlated
-2.78%
LOGC - PCVX
45%
Loosely correlated
+1.93%
RXRX - PCVX
42%
Loosely correlated
+2.03%
DYN - PCVX
41%
Loosely correlated
-4.33%
DNLI - PCVX
38%
Loosely correlated
+1.20%
More